EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
TWINRIX
Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
TWINRIX was generally well tolerated
Adverse reactions considered by the investigator as being at least possibly related to TWINRIX vaccination in adults 1
Adapted from the TWINRIX Product Monograph.
TWINRIX Junior was generally well tolerated
Adverse reactions considered by the investigator as being at least possibly related to TWINRIX Junior vaccination in children *1
Adapted from the TWINRIX Product Monograph.
* Following standard 3-dose schedule (0, 1, 6 months).
† Refers to adverse reactions observed in clinical trials with TWINRIX.
TWINRIX combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine is indicated for active immunization against hepatitis A and hepatitis B virus infection in adults, adolescents, children and infants. 1
TWINRIX will not protect against infection caused by other agents such as hepatitis C, hepatitis E and other pathogens known to infect the liver. It can be expected that hepatitis D will also be prevented by immunization with TWINRIX as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection. 1
This page is for Healthcare Professionals only. If you are not a Healthcare Professional, please visit Twinrix.ca.